Clean Diesel Technologies, Inc. manufactures and distributes light duty vehicle catalysts and heavy duty diesel emissions control systems and products to automakers, integrators, and retrofitters in the United States, Canada, Sweden, and the United Kingdom. The company operates in two divisions, Heavy Duty Diesel Systems and Catalyst. The Heavy Duty Diesel Systems division designs and manufactures verified exhaust emissions control solutions. This division's products include diesel oxidation catalysts, diesel particulate filters, closed crankcase ventilation systems, and alternative fuel products. It also manufactures various exhaust accessories and specialty parts, including connectors, elbows, mounting brackets, clamps, exhaust stacks and guards, and intake air components; and manufactures and distributes diesel and natural gas exhaust and intake parts, as well as fenders, catalytic converter components, numerous brackets, guards, and clamps for mounting and sealing components. In addition, this division produces exhaust and intake components for racing enthusiasts; and manufactures intake and exhaust components for off-road and mining equipment, as well as for diesel and natural gas generators. This division markets its regenerating diesel particulate filters under the Purifilter, Combifilter, Purifier, Actifilter, and Cattrap brand names. The Catalyst division develops and produces catalysts to reduce emissions from gasoline, diesel, and natural gas combustion engines. This division's products include catalysts for gasoline and diesel engines, as well as for energy applications. Clean Diesel Technologies, Inc. sells its products through a network of dealers and distributors, as well as directly to original equipment manufacturers. The company was founded in 1996 and is headquartered in Oxnard, California.
ESB Financial Corporation operates as a thrift holding company for ESB Bank that provides various retail and commercial financial products and services in western Pennsylvania, the United States. It offers various deposit products, including regular savings accounts, checking and money market accounts, certificate accounts, and time deposits. The company also provides single-family and multi-family residential mortgage loans; construction loans; commercial real estate loans; commercial business loans, including credit cards; and consumer loans, such as loans secured by deposit accounts, automobile loans, home equity loans, and secured and unsecured personal loans. In addition, it issues trust preferred securities to the public; and provides residential and commercial loan closing services, as well as title insurance services. Further, the company is engaged in the real estate development and construction of 1-4 family residential units. As of July 17, 2014, it operated 23 offices in Allegheny, Beaver, Butler, and Lawrence counties in Pennsylvania. ESB Financial Corporation was founded in 1915 and is headquartered in Ellwood City, Pennsylvania.
Omeros Corporation, a clinical-stage biopharmaceutical company, discovers, develops, and commercializes products targeting inflammation, coagulopathies, and disorders of the central nervous system. Its clinical products include Omidria, which has completed two Phase III clinical trials for use during intraocular lens replacement, including cataract and other lens replacement surgery; OMS103 that is in Phase III clinical program for use during arthroscopic procedures, such as partial meniscectomy surgery; and OMS824, which is in Phase II clinical trial for the treatment of CNS disorders comprising schizophrenia and Huntington's disease. Its clinical programs also consist of OMS721 that is in Phase II clinical trial for the treatment of various complement-related diseases and disorders, including thrombotic microangiopathies; OMS405, which is in Phase II clinical trial for the treatment and prevention of addiction to substances of abuse; and OMS201 that has completed Phase 1/Phase 2 clinical trial for use during urological procedures, such as ureterscopy for removal of ureteral or renal stones. The company's preclinical products and development programs comprise OMS527 for the treatment of addiction and compulsive disorders, as well as for movement disorders, such as Parkinson's disease; and OMS616 for the control of blood loss during surgery, or resulting from trauma or other hyperfibrinolytic conditions. Its preclinical products also include G protein-coupled receptors platform for multiple disorders across therapeutic area; GPR17 for demyelinating disorders; and antibody platform for the discovery of monoclonal antibodies. Omeros Corporation was incorporated in 1994 and is based in Seattle, Washington.
THT Heat Transfer Technology, Inc., through its subsidiaries, manufactures and trades in plate heat exchangers and various related products in the People's Republic of China. The company primarily offers plate heat exchangers, heat exchanger units, air-cooled heat exchangers, shell-and-tube heat exchangers, welded plate heat exchangers, and plate-and-shell heat exchangers. Its products are used for various applications in iron, steel, and aluminum manufacturing; chemical manufacturing; electric and nuclear power generation; central building air-conditioning; pharmaceutical production; food and beverage industry; high-pressure liquids; thermal power plants and residential heating systems; and in the equipment used in oil refining, the chemical industry, fertilizer production, and metallurgy. The company markets its products directly through its sales force. THT Heat Transfer Technology, Inc. is headquartered in Siping, the People's Republic of China.
Nxt-ID, Inc., a technology company, provides various biometric solutions. The company develops Wocket, a physical electronic wallet that is intended to hold information from credit cards, identification cards, and virtually any magnetic stripe card to allow a specific owner of the card to configure a single electronic card to replicate any of the copied cards; MobileBio VoiceMatch, a method of recognizing speakers and specific words providing multi-factor recognition; and FaceMatch that is intended to serve as a modular facial recognition system for smartphones, tablets, laptop, and desktop computers. It also offers 3D FaceMatch Biometric Identity System, an identity management platform providing fusion of 3D facial recognition, 2D facial recognition, and optional fingerprint biometrics; and 3D SketchArtist, a 3D software face composite sketch tool that makes sketching a face. The company's provides its solutions for securing mobile platforms, as well as for access control and law enforcement facial recognition markets. Nxt-ID, Inc. was founded in 2011 and is headquartered in Shelton, Connecticut.
ABIOMED, Inc. provides medical devices in circulatory support and continuum of care in heart recovery to acute heart failure patients. Its products consist of Impella 2.5 catheter, a percutaneous micro heart pump with integrated motor and sensors for use in interventional cardiology; Impella CP, a micro heart pump; and Impella 5.0 catheter and Impella LD, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite. The company also manufactures and sells the Impella RP, a percutaneous catheter-based axial flow pump; and AB5000 circulatory support system and the BVS 5000 biventricular support system for temporary support of acute heart failure patients in profound shock, including patients suffering from cardiogenic shock after a heart attack, post-cardiotomy cardiogenic shock, or myocarditis. In addition, it offers Symphony, a synchronized minimally invasive implantable cardiac assist device designed to treat chronic patients with moderate heart failure by improving patient hemodynamics; and AbioCor program. The company sells its products through direct sales and clinical support personnel in the United States, Canada, Germany, France, the United Kingdom, and internationally. ABIOMED, Inc. was founded in 1981 and is headquartered in Danvers, Massachusetts.
Lakeland Industries, Inc., together with its subsidiaries, manufactures and sells safety garments and accessories for the industrial protective clothing market worldwide. The company provides limited use/disposable protective clothing, such as coveralls, lab coats, shirts, pants, hoods, aprons, sleeves, and smocks; high-end chemical protective suits to provide protection from highly concentrated and hazardous chemical and biological toxins; and fire fighting and heat protective apparel, which is used for the maintenance of high temperature equipment, and for military and airport crash and rescue teams. It also offers reusable woven garments, including electrostatic dissipative apparel used in the pharmaceutical and automotive industries, clean room apparel to prevent human contamination in the manufacturing processes, flame resistant and fire resistant cotton coveralls used in chemical and petroleum plants and for wild land firefighting, and extrication suits for police and ambulance workers; flame retardant and reflective garments for use in the fire industry, utilities, industrial uniforms, and state departments of transportation; and gloves and sleeves that are used in the automotive, glass, metal fabrication, and food service industries. The company sells its products to a network of approximately 1,200 North American safety and mill supply distributors through a customer service group, regional sales managers, and independent sales representatives. Its products are used by industrial customers, such as integrated oil, chemical/petrochemical, utilities, automobile, steel, glass, construction, smelting, munition plants, janitorial, pharmaceutical, mortuaries, high technology electronics manufacturers, and scientific and medical laboratories, as well as federal, state, and local governmental agencies and departments. The company was founded in 1982 and is headquartered in Ronkonkoma, New York.
Calix, Inc. develops, markets, and sells broadband communications access systems and software for fiber and copper-based network architectures that enable communications service providers (CSPs) to transform their networks and connect to their residential and business subscribers. Its Unified Access portfolio includes main platforms and/or nodes, the B6 Ethernet service access nodes, the C7 multiservice, multiprotocol access platform, the E-Series Ethernet service access platforms and nodes, and the BLM1500 gigabit passive optical network access terminal. The company's platforms, nodes, and terminals also include P-Series and T-Series optical network terminals and residential gateways; and the Calix Management System, Entriview element management software, and Compass suite of value-added software applications. Its portfolio serves the CSP network from the central office or data center to the subscriber premises and enables CSPs to deliver basic voice and data, and broadband services over legacy and next-generation access networks. The company markets its access systems and software to communication service providers in the United States, the Caribbean, Europe, Canada, and internationally through its direct sales force and resellers. Calix, Inc. was founded in 1999 and is headquartered in Petaluma, California.
Trovagene, Inc., a development stage molecular diagnostic company, focuses on the development and commercialization of a proprietary urine-based molecular diagnostic technology. Its technology is used in the detection and monitoring of diseases in various medical disciplines, primarily the management of cancer treatment. The company's proprietary urine-based molecular diagnostic tests are used to detect cell-free DNA and RNA originating from normal and diseased cell death that can be isolated and detected from urine. Its technology is applied in various testing, such as tumor mutation detection and monitoring, infectious disease monitoring, transplantation monitoring, and prenatal genetic diagnostics. The company was formerly known as Xenomics, Inc. and changed its name to Trovagene, Inc. in January 2010. Trovagene, Inc. was founded in 1999 and is headquartered in San Diego, California.
Changyou.com Limited develops and operates online games in the People's Republic of China. The company is primarily involved in the development, operation, and licensing of massively multi-player online games (MMOGs), which are interactive online games that might be played simultaneously by various game players; Web-based games, which are played over the Internet using a Web browser; and mobile games, which are played on mobile devices and require an Internet connection. The company operates various MMOGs that include Tian Long Ba Bu, Blade Online series, Duke of Mount Deer, Da Hua Shui Hu, Wartune, Dou Po Cang Qiong, and DDTank. It also owns and operates the 17173.com Website, a game information portal in China; 37wanwan.com Website, a games portal that provides a collection of Web games; and Raidcall, a communication software that is used by professionals and gamers. As of December 31, 2013, it had approximately 25 million total average monthly active accounts for games; and 149 million total average monthly active accounts for platform channels. The company was founded in 2003 and is headquartered in Beijing, the People's Republic of China. Changyou.com Limited is a subsidiary of Sohu.com Inc.